0001493152-23-025759.txt : 20230728 0001493152-23-025759.hdr.sgml : 20230728 20230728080033 ACCESSION NUMBER: 0001493152-23-025759 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20230728 FILED AS OF DATE: 20230728 DATE AS OF CHANGE: 20230728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENETIC TECHNOLOGIES LTD CENTRAL INDEX KEY: 0001166272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51504 FILM NUMBER: 231120255 BUSINESS ADDRESS: STREET 1: 60-66 HANOVER STREET CITY: FITZROY, VICTORIA STATE: C3 ZIP: 3065 BUSINESS PHONE: 011613-9415-1135 MAIL ADDRESS: STREET 1: 60-66 HANOVER STREET CITY: FITZROY, VICTORIA STATE: C3 ZIP: 3065 6-K 1 form6-k.htm

 

 

 

FORM 6-K

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

dated July 28, 2023

 

Commission File Number 0-51504

 

GENETIC TECHNOLOGIES LIMITED

(Exact Name as Specified in its Charter)

 

N/A

(Translation of Registrant’s Name)

 

60-66 Hanover Street

Fitzroy

Victoria 3065 Australia

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ☐ No ☒

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable.

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused the Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 28, 2023

 

  GENETIC TECHNOLOGIES LIMITED
   
  By: /s/ Tony Di Pietro
  Name: Tony Di Pietro
  Title: Company Secretary

 

2

 

 

EXHIBIT INDEX

 

Exhibit   Description of Exhibit
     
99.60   Appendix 4C & Quarterly Business Update – June 2023

 

3

 EX-99.60 2 ex99-60.htm

 

Exhibit 99.60

 

 

Appendix 4C & Quarterly Business Update – June 2023

 

Encouraging Growth for geneType Commercial Test Volume

 

Melbourne, Australia, 28 July 2023: Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, releases its Appendix 4C and Quarterly Business Update for the quarter ending 30 June 2023 (Q4 FY23).

 

Highlights:

 

● June Quarter FY23 receipts were A$2.1 million.  
● Receipts from customers was A$8.8 million for the 12 months to 30 June 2023, up 29% on the prior corresponding period.  
● GeneType Multi-risk test gaining traction with 250% growth in commercial samples received compared with the prior quarter off a low initial base.  
● 20 Medical practices in the U.S. and Australia now repeatedly referring samples for geneType testing – adding new practices incrementally every week.  
● Launched a National Television campaign in the U.S. driving engagement with consumers.  
● Presented a poster at The American Society of Clinical Oncologists (ASCO) in Chicago in May.  
● Attended the annual Biotechnology Innovation Organisation (BIO) conference in Boston to establish global partnership foundation pathways.  
● Publications validating the use of geneType; identifying those at elevated risk of developing Melanoma, Pancreatic and Prostate Cancer.  

 

Commenting on the Company’s quarterly performance, Chief Executive Officer Simon Morriss said: “The June 2023 quarter provided some significant highlights. Growth in the commercial traction of the company’s geneType brand was experienced in both Australia and the U.S. This is being driven by a strengthened focus on sales and support, via our newly appointed Medical Science Liaison (MSL) team and our dedicated technical and customer support teams in the U.S. and Australia.

 

“Our science team continues to deliver, growing the geneType platform with peer reviewed publications accepted for three of the recently included diseases on the geneType platform. Studies have again validated the utility of the melanoma, prostate and pancreatic cancer tests, continuing to highlight the strong scientific “DNA” that provides a clinical foundation for geneType “.

 

Genetic Technologies Limited

 60-66 Hanover Street

www.genetype.com

 Fitzroy Victoria 3065

info@gtglabs.com

 Australia

ABN 17 009 212 328

 +61 3 8412 7000

 

 
 

 

 

Key Achievements During the Quarter

 

GeneType Commercial Progress Update

 

Adoption of geneType continues to grow strongly in both Australia and the U.S., with a significant increase in the number of commercial samples processed through the company’s NATA accredited, CLIA Certified Melbourne facility. GTG’s teams in Australia and the U.S. are adding 2-3 new referring practices every week, providing a solid foundation for the continued commercial sales growth of geneType.

 

In the U.S., the company is progressing discussions to initiate a pilot study to determine the clinical utility of the geneType Breast Cancer Risk Assessment Test with a mid-west based employer group. Demonstrating clinical utility through this employer group will provide strong support for the use of geneType with members of the employer group. Success with this initiative should encourage other employer groups and U.S. insurers, to recommend and use the geneType test as a valuable and life saving screening test.

 

Early detection saves lives, as well as reducing the significant cost of treating serious disease, including cancer.

 

Peer-reviewed Studies Validating GeneType for Melanoma, Pancreatic and Prostate Cancers Risk Assessment

 

GeneType for Pancreatic Cancer Risk Assessment showed a nearly 50% improvement in identifying individuals with a high risk of developing pancreatic cancer and, when paired with existing or emerging pancreatic screening techniques, will lead to clinically significant earlier diagnosis of pancreatic cancer. Identifying “at-risk individuals” early, when surgical intervention is still possible, will lead to significantly improved patient outcomes1 2.

 

Chief Executive Officer, Simon Morriss, said: “Pancreatic Cancer is a deadly disease, 65,000 people will be diagnosed with pancreatic in the U.S. this year and 50,000 people will die3. This devastating statistic is driven by late diagnosis of this cancer. Implementing geneType risk assessment test for pancreatic cancer will help doctors diagnose the disease and intervene earlier, reducing this appalling mortality. This test really can make a difference in improving patient outcomes.”

 

The Prostate Cancer study, involving a prospective cohort of almost 200,000 men from the UK Biobank, demonstrated that the geneType Prostate Cancer Risk Assessment Test offered a significant improvement in risk assessment when compared with age and family history in assessing a man’s risk of developing prostate cancer. The study concluded that family history alone had a 23% underestimation of risk. Importantly, geneType was also able to identify men at very low risk of developing prostate cancer.

 

The Melanoma study used participant samples from the UK Biobank to develop a new Polygenic Risk Score (PRS) for melanoma comprising 68 single nucleotide polymorphisms (SNPs). The study identified the top 20% of people who were at 2.3 times increased risk of Melanoma compared to the population average, by combining the PRS and a clinical risk score to predict 10-year risk of Melanoma.

 

Commenting on the results of these studies, Dr Erika Spaeth, GTG’s Director of Clinical & Medical Affairs, stated “Risk awareness can inform decision making between clinicians and their patients enabling them to discuss the benefits of screening and ultimately lead to early diagnosis of these serious diseases”.

 

 

 

1 Canto MI, Almario JA, Schulick RD, et al. Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology. 2018; 155(3): 740-751 e742. doi:10.1053/j.gastro.2018.05.035

2 Vasen H, Ibrahim I, Ponce CG, et al. Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers. J Clin Oncol. 2016; 34(17): 2010-2019. doi:10.1200/JCO.2015.64.0730

3 https://www.cancer.org/cancer/types/pancreatic-cancer/about/key-statistics.html

 

Genetic Technologies Limited

 60-66 Hanover Street

www.genetype.com

 Fitzroy Victoria 3065

info@gtglabs.com

 Australia

ABN 17 009 212 328

 +61 3 8412 7000

 

 
 

 

 

Financial and Cashflow Overview

 

At the end of June 2023, GTG had A$7.9 million in cash and cash equivalents. Cash receipts from customers for the financial year were A$8.8 million with the refund of the R & D Tax Incentive for the 2022 financial year contributing

 

$2.0 million and interest receipts adding $0.2m. Cash outflow used from operating activities was A$9.9 million for the financial year. The Company received a net $6.3m from the issue of equity early in the calendar year.

 

During the quarter, the Company made $96k of payments to related parties of the entity, and their associates, disclosed at item 6.1 of the Appendix 4C. The payments related to director fees and consulting fees (inclusive of GST) on normal commercial terms.

 

Authorised for release by the Board of Genetic Technologies Limited

 

-END-

 

Enquiries

 

Investor Relations
Adrian Mulcahy
Automic Markets
M: +61 438 630 411
E: Adrian.mulcahy@automicgroup.com.au

 

About Genetic Technologies Limited

 

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products. For more information, please visit www.genetype.com

 

Forward Looking Statements

 

This announcement may contain forward-looking statements about the Company’s expectations, beliefs or intentions regarding, among other things, statements regarding the expected use of proceeds. In addition, from time to time, the Company or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,” “should” or “anticipate” or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by the Company with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of the Company’s authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. As forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause the Company’s actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause the Company’s actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements as detailed in the Company’s filings with the Securities and Exchange Commission and in its periodic filings with the ASX in Australia and the risks and risk factors included therein. In addition, the Company operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. The Company does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Genetic Technologies Limited

 60-66 Hanover Street

www.genetype.com

 Fitzroy Victoria 3065

info@gtglabs.com

 Australia

ABN 17 009 212 328

 +61 3 8412 7000

 

 
 

 

Appendix 4C

 

Quarterly cash flow report for entities

subject to Listing Rule 4.7B

 

Name of entity    
     
Genetic Technologies Limited
     
ABN   Quarter ended (“current quarter”)
     
17 009 212 328   30 June 2023

 

Consolidated statement of cash flows  Current quarter $A’000  

Year to date

(12 months)
$A’000

1. Cash flows from operating activities   2,084   8,771
1.1 Receipts from customers     
1.2 Payments for   (168)  (823)
  (a) research and development     
  (b) product manufacturing and operating costs   (1,203)  (4,853)
  (c) advertising and marketing   (605)  (2,766)
  (d) leased assets   (86)  (337)
  (e) staff costs   (1,491)  (6,436)
  (f) administration and corporate costs   (1,301)  (5,640)
1.3 Dividends received (see note 3)   -   -
1.4 Interest received   85   191
1.5 Interest and other costs of finance paid   -   -
1.6 Income taxes paid   -   -
1.7 Government grants and tax incentives   -   1,959
1.8 Other (provide details if material)   -   -
1.9 Net cash from / (used in) operating activities   (2,685)  (9,934)
           
2. Cash flows from investing activities        
2.1 Payments to acquire or for:        
  (a) entities   -   -
  (b) businesses   -   (486)
  (c) property, plant and equipment   (12)  (17)
  (d) investments   -   -
  (e) intellectual property   -   -
  (f) other non-current assets   -   -
             
2.2 Proceeds from disposal of:         
  (a) entities   -   - 
  (b) businesses   -   - 
  (c) property, plant and equipment   -   - 
  (d) investments   -   - 
  (e) intellectual property   -   - 
  (f) other non-current assets   -   - 
2.3 Cash flows from loans to other entities   -   - 
2.4 Dividends received (see note 3)   -   - 
2.5 Other (provide details if material)   -   - 
2.6 Net cash from / (used in) investing activities   (12)  (503)

 

 

ASX Listing Rules Appendix 4C (17/07/20) Page 1
+ See chapter 19 of the ASX Listing Rules for defined terms.  

 

 

 

 

Appendix 4C

Quarterly cash flow report for entities subject to Listing Rule 4.7B

 

Consolidated statement of cash flows   Current quarter $A’000    

Year to date

(6 months) $A’000 

 
3. Cash flows from financing activities          
3.1 Proceeds from issues of equity securities (excluding convertible debt securities)   -    7,172 
3.2 Proceeds from issue of convertible debt securities   -    - 
3.3 Proceeds from exercise of options   -    - 
3.4 Transaction costs related to issues of equity securities or convertible debt securities   -    (852)
3.5 Proceeds from borrowings   -    - 
3.6 Repayment of borrowings   -    - 
3.7 Transaction costs related to loans and borrowings   -    - 
3.8 Dividends paid   -    - 
3.9 Other (provide details if material)   -    6,320 
3.10 Net cash from / (used in) financing activities   -    - 
             
4. Net increase / (decrease) in cash and cash equivalents for the period          
4.1 Cash and cash equivalents at beginning of period   10,481    11,733 
4.2 Net cash from / (used in) operating activities (item 1.9 above)   (2,685)   (9,934)
4.3 Net cash from / (used in) investing activities (item 2.6 above)   (12)   (503)
4.4 Net cash from / (used in) financing activities (item 3.10 above)   -    6,320 
4.5 Effect of movement in exchange rates on cash held   69   237 
4.6 Cash and cash equivalents at end of period   

7,853

    7,853 

 

 

ASX Listing Rules Appendix 4C (17/07/20) Page 2
+ See chapter 19 of the ASX Listing Rules for defined terms.  

 

 

 

 

Appendix 4C

Quarterly cash flow report for entities subject to Listing Rule 4.7B

 

5.

Reconciliation of cash and cash equivalents

at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

  Current quarter
$A’000		   Previous quarter
$A’000		 
5.1 Bank balances   3,153    2,044 
5.2 Call deposits   4,700    8,437 
5.3 Bank overdrafts   -    - 
5.4 Other (provide details)   -    - 
5.5 Cash and cash equivalents at end of quarter (should equal item 4.6 above)   7,853    10,481 

 

6. Payments to related parties of the entity and their associates  Current quarter
$A’000		 
6.1 Aggregate amount of payments to related parties and their associates included in item 1   96 
6.2 Aggregate amount of payments to related parties and their associates included in item 2   - 
        

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

 

During the quarter, the Company made payments to related parties of the entity and their associates as disclosed in Item 6.1 of the Appendix 4C amounting to $96k. The payments related to the director fees and consulting fees (inclusive of GST) on normal commercial terms.

 

 

ASX Listing Rules Appendix 4C (17/07/20) Page 3
+ See chapter 19 of the ASX Listing Rules for defined terms.  

 

 

 

 

Appendix 4C

Quarterly cash flow report for entities subject to Listing Rule 4.7B

 

7.

Financing facilities

 

Note: the term “facility’ includes all forms of financing arrangements available to the entity.

 

Add notes as necessary for an understanding of the sources of finance available to the entity.

  Total facility amount at quarter end
$A’000		   Amount drawn at quarter end
$A’000		 
7.1 Loan facilities   -    - 
7.2 Credit standby arrangements   -    - 
7.3 Other (please specify)   189    16 
7.4 Total financing facilities   189    16 
             
7.5 Unused financing facilities available at quarter end           173 

 

7.6 Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

 

  1. Secured – Bank of America, US$25,000 facility with interest at 9.25%
  2. Unsecured – National Australia Bank, $150,000 facility with interest at 15.5%

 

8. Estimated cash available for future operating activities  $A’000 
8.1 Net cash from / (used in) operating activities (item 1.9)   (2,685)
8.2 Cash and cash equivalents at quarter end (item 4.6)   7,853 
8.3 Unused finance facilities available at quarter end (item 7.5)   173 
8.4 Total available funding (item 8.2 + item 8.3)   8,026 
        
8.5 Estimated quarters of funding available (item 8.4 divided by item 8.1)   2.99 
        
  Note: if the entity has reported positive net operating cash flows in item 1.9, answer item 8.5 as “N/A”. Otherwise, a figure for the estimated quarters of funding available must be included in item 8.5.

 

8.6   If item 8.5 is less than 2 quarters, please provide answers to the following questions:
     
  8.6.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?
     
  Answer: N/A
     
  8.6.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?
     
  Answer: N/A
     
  8.6.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?
     
  Answer: N/A
     
  Note: where item 8.5 is less than 2 quarters, all of questions 8.6.1, 8.6.2 and 8.6.3 above must be answered.

 

 

ASX Listing Rules Appendix 4C (17/07/20) Page 4
+ See chapter 19 of the ASX Listing Rules for defined terms.  

 

 

 

 

Appendix 4C

Quarterly cash flow report for entities subject to Listing Rule 4.7B

 

Compliance statement

 

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.
   
2 This statement gives a true and fair view of the matters disclosed.

 

Date:

28 July 2023

   
Authorised by: Tony Di Pietro
  CFO & Company Secretary

 

Notes

 

1.This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity’s activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

 

2.If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standard applies to this report.

 

3.Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

 

4.If this report has been authorised for release to the market by your board of directors, you can insert here: “By the board”. If it has been authorised for release to the market by a committee of your board of directors, you can insert here: “By the [name of board committee – eg Audit and Risk Committee]”. If it has been authorised for release to the market by a disclosure committee, you can insert here: “By the Disclosure Committee”.

 

5.If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendation 4.2 of the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

 

 

ASX Listing Rules Appendix 4C (17/07/20) Page 5
+ See chapter 19 of the ASX Listing Rules for defined terms.  

 

 

 

 

 

 

 GRAPHIC 3 ex99-60_002.jpg begin 644 ex99-60_002.jpg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end GRAPHIC 4 ex99-60_001.jpg begin 644 ex99-60_001.jpg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end GRAPHIC 5 ex99-60_003.jpg begin 644 ex99-60_003.jpg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end